Hypoglycemic Agent Targets and Susceptibility to Lower Respiratory Infection: A Pharmacogenomic Mendelian Randomization Study
Genes · 2026
DOI: 10.3390/genes17101258 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2026. Verfasst von Taikang Yao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Peking University Third Hospital, No. 49 Huayuan North Road, Haidian District, Beijing 100191, Ch…. Hauptthemen laut MEDLINE: Hypoglycemic Agents, Respiratory Tract Infections, Diabetes Mellitus, Type 2. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Key Clinical Specialty Funding, National Natural Science Foundation of China, the Research Project of Peking University Third Hospital in National Key Laboratory of Vascular Homeostasis and Remodeling.
Abstract (Originalsprache)
Background/Objectives: Patients with type 2 diabetes face heightened risks of lower respiratory tract infections, but whether distinct glucose-lowering drug targets differentially alter pulmonary susceptibility remains unclear. We investigated how genetically proxied perturbations of major antidiabetic targets relate to respiratory infection and sepsis risks.
Methods
Using two-sample drug-target Mendelian randomization, we examined genetic instruments proxying six antidiabetic pathways: insulin (INSR), sulfonylureas (KCNJ11/ABCC8), thiazolidinediones (PPARG), GLP-1 receptor agonists (GLP1R), SGLT2 inhibitors (SLC5A2), and metformin (GPD1, GPD2, PRKAG2). Associations were calibrated to standardized glycemic decrements and tested across 13 respiratory infection and sepsis GWAS outcomes. Analyses incorporated functional-variant comparisons, a type 2 diabetes positive control, and linkage disequilibrium adjustment.
Results
Genetically proxied glucose lowering through PPARG showed consistent nominal associations with increased respiratory infection risk. Per 0.1 mmol/L lower glucose, the primary proxy and Pro12Ala functional variant were associated with higher odds of influenza and pneumonia (odds ratio [OR] 1.53, 95% CI 1.16–2.02, p = 0.003; and OR 1.53, 95% CI 1.13–2.06, p = 0.006) and other acute lower respiratory infections (OR 1.78, 95% CI 1.14–2.77, p = 0.011; and OR 1.87, 95% CI 1.16–3.01, p = 0.010). PPARG primary and functional proxies agreed in direction for 10/13 outcomes, whereas potassium-channel proxies agreed for only 3/13. Other targets showed distinct, heterogeneous patterns. Crucially, all signals were nominal and none survived false discovery rate correction (q ≥ 0.05).
Conclusions
Genetically proxied glucose-lowering pathways exhibit divergent associations with respiratory infection susceptibility. While findings do not support class-wide causal risks, the repeated PPARG pattern highlights target-specific pulmonary immune mechanisms warranting functional and clinical investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, Peking University Third Hospital, No. 49 Huayuan North Road, Haidian District, Beijing 100191, China.
- Center for Infectious Diseases, Peking University Third Hospital, No. 49 Huayuan North Road, Haidian District, Beijing 100191, China.
- Department of Respiratory and Critical Care Medicine, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing 100044, China.
- National Key Laboratory of Vascular Homeostasis and Remodeling, Peking University Health Science Center, No. 38 Xueyuan Road, Haidian District, Beijing 100191, China.
ORCID-Profile: Taikang Yao, Zhenchao Wu, Ning Shen
Förderung
- Beijing Key Clinical Specialty Funding
- National Natural Science Foundation of China
- the Research Project of Peking University Third Hospital in National Key Laboratory of Vascular Homeostasis and Remodeling
- Beijing Natural Science Foundation
- Open Project of Peking University Joint Laboratory of Human Microbiome
- Clinical Key Project of Peking University Third Hospital
- National Natural Science Foundation of China for Young Scientists
Zitieren
APA
Yao, T., Wu, N., Ma, Y., Wang, Z., Liu, B., Lu, M., Wu, Z., & Shen, N. (2026). Hypoglycemic Agent Targets and Susceptibility to Lower Respiratory Infection: A Pharmacogenomic Mendelian Randomization Study. Genes. https://doi.org/10.3390/genes17101258
Vancouver
Yao T, Wu N, Ma Y, Wang Z, Liu B, Lu M, et al. Hypoglycemic Agent Targets and Susceptibility to Lower Respiratory Infection: A Pharmacogenomic Mendelian Randomization Study. Genes. 2026. doi:10.3390/genes17101258
BibTeX
@article{Yao2026,
author = {Yao, Taikang and Wu, Nan and Ma, Yanqiu and Wang, Zilu and Liu, Beibei and Lu, Ming and Wu, Zhenchao and Shen, Ning},
title = {Hypoglycemic Agent Targets and Susceptibility to Lower Respiratory Infection: A Pharmacogenomic Mendelian Randomization Study},
journal = {Genes},
year = {2026},
doi = {10.3390/genes17101258}
}
EUVIMED